Longevity & Anti-Aging17 June 2026 · 5 min read

Peptides for Skin: Collagen, Elasticity and Glow

Peptides are among the most evidence-backed interventions for skin aging, working through collagen synthesis, angiogenesis, and anti-inflammatory mechanisms. Here is what the science shows.

By Longegra Clinical Team

Skin aging is one of the most visible manifestations of the biological aging process. The wrinkles, thinning, loss of elasticity, and reduced luminosity that develop over time are not cosmetic concerns in isolation; they are visible evidence of the same collagen degradation, vascular decline, and inflammatory processes that affect every tissue in the body.

Peptides address skin aging at the biological level, working through the same mechanisms of collagen synthesis, angiogenesis, and anti-inflammatory signalling that make them effective for tissue repair throughout the body.

Why Skin Ages

Skin aging results from two overlapping processes:

  • Intrinsic aging: The genetically programmed decline in fibroblast activity, collagen synthesis, and cellular renewal that occurs regardless of external factors. This reduces skin thickness, density, and elasticity progressively from the mid-thirties onward.
  • Extrinsic aging: Accelerated by UV exposure (photoaging), smoking, oxidative stress, poor sleep, and chronic inflammation. Responsible for the majority of visible skin aging in most adults.

The key biological changes:

  • Dermal collagen content declines by approximately 1% per year after age 25
  • Collagen cross-linking increases, reducing elasticity
  • Hyaluronic acid (the primary skin hydrator) declines, reducing volume and moisture retention
  • Dermal vascularity decreases, reducing nutrient delivery and skin luminosity

The Key Peptides for Skin Health

GHK-Cu: The Most Evidence-Backed Skin Peptide

GHK-Cu (copper tripeptide) stimulates fibroblasts to produce collagen types I and III, glycosaminoglycans (including hyaluronic acid), and elastin. Published randomised controlled trials confirm:

  • Measurable reduction in fine line depth and wrinkle area after 12 weeks of daily topical use
  • Improved skin density and firmness
  • Reduced barrier permeability
  • Enhanced wound healing and scar reduction

GHK-Cu's anti-inflammatory activity also reduces the chronic skin inflammation that accelerates extrinsic aging.

Growth Hormone Peptides (CJC-1295, Ipamorelin): Systemic Collagen Support

IGF-1 is a powerful stimulator of fibroblast activity and collagen synthesis throughout the body, including in skin. The skin quality improvements reported by patients on GH peptide programs (improved texture, firmness, and skin thickness) are mediated largely by elevated IGF-1 acting on dermal fibroblasts.

This represents an inside-out approach to skin aging: rather than applying topical actives to isolated skin patches, restoring systemic IGF-1 supports collagen maintenance throughout all skin tissue simultaneously.

BPC-157: Angiogenesis and Skin Repair

BPC-157's angiogenic effects improve dermal vascularity, the blood supply to skin that supports nutrient delivery, cellular renewal, and the luminosity that comes from well-perfused skin. This is particularly relevant for photoaged skin with reduced microvascular density.

Epitalon: Circadian and Melatonin Support for Skin

Melatonin has direct antioxidant effects in skin and plays a role in the circadian rhythm of skin cell repair. Sleep is the period of peak skin regeneration. Epitalon's restoration of melatonin production through pineal support has indirect but meaningful benefits for skin health.

Diagram showing how each skin-relevant peptide works through a different mechanism: GHK-Cu at fibroblasts, IGF-1 at the dermal layer, BPC-157 at vascularity

Topical vs Systemic Approaches

ApproachAdvantagesLimitations
Topical GHK-CuHigh local concentration, daily convenience, RCT evidenceOnly reaches superficial skin layers
Systemic GH peptidesFull-body collagen support, multiple skin layers, systemic IGF-1Requires injection, slower skin-specific results
CombinedAddresses both local and systemic driversMore complex protocol

For patients whose primary goal is skin quality, combining topical GHK-Cu with systemic GH peptides provides the most comprehensive approach. The topical treatment delivers high concentrations to the superficial dermis; the systemic IGF-1 elevation supports the deeper dermal architecture.

What Peptides Cannot Replace

Peptides address the biological drivers of skin aging. They work best alongside (not instead of):

  • Sun protection: UV damage is the single largest driver of extrinsic skin aging. No peptide compensates for continued photoexposure.
  • Sleep quality: The skin's repair processes are maximised during sleep. GH peptides and Epitalon support this, but adequate sleep duration is non-negotiable.
  • Hydration and nutrition: Adequate protein provides the amino acid substrate for collagen synthesis that peptides stimulate.

Timeline for Skin Improvements

  • Weeks 2 to 4: Improved hydration and early glow (hyaluronic acid and vascular effects)
  • Months 2 to 3: Reduced fine line depth, improved skin texture (collagen synthesis accumulation)
  • Months 3 to 6: Measurable improvements in skin density and elasticity
  • Six months and beyond: Continued accumulation of collagen maintenance effects

Frequently Asked Questions (FAQs)

They work through different mechanisms. Hyaluronic acid serums provide immediate hydration by attracting water to the skin surface. GHK-Cu stimulates the fibroblast activity that produces the skin's own hyaluronic acid and collagen. GHK-Cu addresses the underlying biology; hyaluronic acid serums address the symptom. Both can be used together.

More clinician-reviewed guides from the Longegra library.